Fertility and pregnancy after breast cancer

Breast

Volumn 15, Issue SUPPL. 2, 2006, Pages

  Jones, Alison Louise ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; BRCA1 PROTEIN; BRCA2 PROTEIN; BUSERELIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ESTROGEN; FLUOROURACIL; FOLLITROPIN; GOSERELIN; LETROZOLE; LUTEINIZING HORMONE; METHOTREXATE; STEROID RECEPTOR; TAMOXIFEN;

AMENORRHEA; ARTICLE; BONE DENSITY; BONE MINERAL; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVOR; CARDIOVASCULAR RISK; COMBINATION CHEMOTHERAPY; EMBRYO TRANSFER; ESTROGEN BLOOD LEVEL; FEMALE FERTILITY; FERTILIZATION IN VITRO; GENE MUTATION; HEALTH SURVEY; HUMAN; LOW DRUG DOSE; MEDICAL DECISION MAKING; MENOPAUSE; MENSTRUAL CYCLE; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; OLIGOMENORRHEA; ONSET AGE; ORGAN PRESERVATION; OSTEOLYSIS; OVULATION INDUCTION; OVULATION INHIBITION; PREGNANCY; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RISK ASSESSMENT; SIDE EFFECT; SINGLE DRUG DOSE; SOCIAL PSYCHOLOGY; UNITED KINGDOM;

ADULT; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; INFERTILITY, FEMALE; PREGNANCY; PREGNANCY OUTCOME;

EID: 33947256792     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9776(07)70017-6     Document Type: Article

References (30)

1. Kroenke C., Rosner B., Chen W., et al. Functional impact of breast cancer by age at diagnosis. J Clin Oncol 22 (2004) 1849-1856
2. Bines J., Oleske D., and Cobleigh M. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 14 (1996) 1718-1729
3. Minton S., and Munster P. Chemotherapy-induced amenorrhoea and fertility in women undergoing adjuvant treatment for breast cancer. Cancer Control 9 (2002) 466-472
4. Hortobagyi G., Buzdar A., Marcus C., et al. Immediate and long-term toxicity of adjuvant chemotherapy regimens containing doxorubicin in trials at M.D. Anderson Hospital and Tumor Institute. NCI Monogr 1 (1986) 105-109
5. Goodwin P., Ennis P., Pritchard K., et al. Risk of menopause during the first year after breast cancer diagnosis. J Clin Oncol 17 (1999) 2365-2370
6. Lutchman Singh K., Danes M., and Chatterjee R. Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing. Hum Reprod Update 11 (2005) 68-69
7. Gelber S., Coates S., Goldhirsch A., et al. Effect of pregnancy on overall survival after the diagnosis of early-stage breast cancer. J Clin Oncol 19 (2001) 1671-1675
8. Mueller B., Simon M., Deapen D., et al. Child bearing and survival after breast carcinoma in young women. Cancer 98 (2003) 1131-1140
9. Blakely L., Buzdar A., Lozarda J., et al. Effects of pregnancy after treatment for breast cancer on survival and risk of recurrence. Cancer 100 (2004) 465-469
10. Kroman N., and Mouriden H. Prognostic influence of pregnancy before, around and after diagnosis of breast cancer. Breast 12 (2003) 516-521
11. Langagergaard V., Gislum M., Skriver M., et al. Birth outcome in women with breast cancer. Br J Cancer 94 (2006) 142-146
12. Cullinane C., Lubinski J., Neuhausen S., et al. Effect of pregnancy as a risk for breast cancer in BRCA1/BRCA2 mutation carriers. Int J Cancer 117 (2005 Dec 20) 988-991
13. Smith K., Ellington L., Chan A., et al. Fertility intentions following testing for a BRCA1 gene mutation. Cancer Epidemiol Biomarkers Prev 13 (2004) 733-740
14. Duffy C., Allan S., and Clarke M. Discussions regarding reproductive health for young women with breast cancer undergoing chemotherapy. J Clin Oncol 23 (2005) 766-773
15. Partridge A., Gelber S., Peppercorn J., et al. Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol 22 (2004) 4174-4183
16. Thewes B., Meiser B., et al. Fertility in menopauserelated information needs of younger women with a diagnosis of early breast cancer. J Clin Oncol 23 (2005) 5155-5165
17. Thewes B., Meiser B., Duric V., et al. What survival benefits do premenopausal women with early breast cancer need to make endocrine therapy worthwhile. Lancet Oncol 6 (2005) 581-588
18. Recchia F., Gigliola S., De Filippis M., and Rea S. Ovarian protection with goserelin during chemotherapy for early breast cancer: long-term results of a phase II study. Proc Am Soc Clin Oncol (2002) Abstract 162.
19. Recchia F., Saggio G., Amiconi G., et al. Gonadotropinreleasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma. Cancer 106 (2006) 514-523
20. Klopper A., and Hall M. New synthetic agent for the induction of ovulation: preliminary trials in women. BMJ 1 (1971) 152-154
21. Shetty G., Krishnamurthy H., Krishnamurthy H., et al. Effective oestrogen deprivation on the reproductive physiology of male and female primates. J Steroid Biochem Mol Biol 61 (1997) 157-166
22. Mitwalli M., and Casper R. Aromatase inhibitions in ovulation induction. Semin Reprod Med 22 (2004) 61-78
23. Oktay K., Buyuk E., Libertella N., et al. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol 23 (2005) 4347-4353
24. Fisk N., Templeton A., Papadopoulo S., et al. Lack of effect of high-dose anti-oestrogens on the maturation and in-vitro fertilisation of human oocytes. Hum Reprod 4 (1989) 584-587
25. Schoolcraft W., Surrey E., Minjannez D., et al. Antagonist/letrozole protocol for patients failing microdose agonist flare stimulation. Fertil Steril 78 (2002) S234
26. Gosden K. Prospects for oocyte banking and in-vitro maturation. J Natl Cancer Inst Monogr 34 (2005) 60-63
27. Oktay K., Buyuk E., Veeck L., et al. Embryo development after heterotopic transplantation of cryopreserved ovarian tissue. Lancet 363 (2004) 837-840
28. Gauthier E., Paoletti X., Clavel-Chapelon F., and E3N Group. Breast cancer risk associated with being treated for infertility: results from the French E3N Cohort Study. Hum Reprod 19 (2004) 2216-2221
29. Siegelman-Danieli M., Tamir A., Zohar H., et al. Breast cancer in women with recent exposure to fertility medications is associated with poor prognostic features. Ann Surg Oncol 10 (2003) 1031-1038
30. Robertson J. Cancer and fertility: ethical and legal challenges. J Natl Cancer Inst Monogr 34 (2005) 104-106